Progress FDA Submission

TransEnterix, Inc. Reports Progress on Senhance FDA Submission

September 18, 2017 RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the…